Anti-cd28 x anti-trop2 antibodies (Xencor)

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameAnti-cd28 x anti-trop2 antibodies (Xencor)

Drug Alias Nameanti-CD28/anti-TROP2 T-cell engager (Xencor)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-Trop-2Anti-CD28

TargetsTumor-associated calcium signal transducer 2T-cell-specific surface glycoprotein CD28

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesXencor Inc

China Registration ClassN/A

Develop Information

Active CompaniesXencor Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A